Minas P Economides

6PUBLICATIONS
5CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 02, 2021
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes.

Andrew L Laccetti, Benjamin Garmezy, Lianchun Xiao

|Oct 04, 2019
Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm.

Minas P Economides, Marina Konopleva, Naveen Pemmaraju

|Aug 30, 2019
Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm.

Minas P Economides, Deborah McCue, Andrew A Lane

|Nov 18, 2017
Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.

Minas P Economides, Moran Amit, Parag S Mahale

|Oct 20, 2017
Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.

Jeff Hosry, Roberto N Miranda, Felipe Samaniego

|Feb 03, 2017
Letter: should direct-acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus-infected patients with cancer? Authors' reply.

M P Economides, T L Shigle, H A Torres

Pageof 1

Frequent Collaborators

2 joint publications

Jeff J Hosry

1 joint publications

Andrew L Laccetti

1 joint publications

Tian Zhang

1 joint publications

Parag S Mahale